HC
LLY icon

Headland Capital’s Eli Lilly LLY Stock Holding History

Headland Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-220
Closed -$236K – 68
2025
Q4 		$236K Buy
+220
New +$210K 0.07% 59
2025
Q1 		– Sell
-296
Closed -$228K – 65
2024
Q4 		$228K Buy
+296
New +$245K 0.08% 48

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Headland Capital's LLY Position: Q1 2026 in Review

Headland Capital sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 220 shares — an estimated $236K sold.

Headland Capital first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $236K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Headland Capital reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Headland Capital sold 220 Eli Lilly shares in Q1 2026, an estimated $236K.
  • Headland Capital first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
  • Headland Capital's Eli Lilly position peaked at $236K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Headland Capital's 13F filing for Q1 2026, filed 4 May 2026.